European Biotech Acquisition Corp. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2021 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
European Biotech Acquisition Corp. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2021 to Q4 2022.
  • European Biotech Acquisition Corp. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2022 was -$969K, a 115% decline year-over-year.
  • European Biotech Acquisition Corp. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2022 was $343K, a 76.8% decline year-over-year.
  • European Biotech Acquisition Corp. annual Net Income (Loss) Attributable to Parent for 2022 was $343K, a 76.8% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $343K -$969K -$518K -115% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-28
Q3 2022 $860K -$400K -$1.6M -133% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $2.46M $201K -$273K -57.6% Apr 1, 2022 Jun 30, 2022 10-Q 2022-11-14
Q1 2022 $2.73M $1.51M +$1.26M +493% Jan 1, 2022 Mar 31, 2022 10-Q 2022-11-14
Q4 2021 $1.48M -$451K Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 $1.2M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $474K Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 $255K Jan 8, 2021 Mar 31, 2021 10-Q 2022-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.